Skip to main content

Etiological Factors Causing Lower Respiratory Tract Infections Isolated from Hospitalized Patients

  • Chapter
  • First Online:
Respiratory Infections

Abstract

Lower respiratory tract infections (LRTI) account for 20–30 % of all hospital-acquired contagions. They are characterized by high mortality of hospitalized patients. The most serious form of LRTI is pneumonia, and the most common etiological factors in such cases are bacteria. The article gives the analysis of bacterial flora samples obtained from lower respiratory tract of hospitalized patients. In vitro susceptibility of pathogens to selected antibiotics has also been assessed. We carried out a retrospective analysis of 1,171 bacterial strains isolated from 1,171 patients treated in clinics of the Military Institute of Medicine in Warsaw, Poland. In most cases the samples were collected from an endotracheal or tracheostomic tube (71.5 %) and from bronchoalveolar lavage (21.7 %). The most commonly isolated pathogens included Acinetobacter baumannii (35.8 %), Staphylococcus aureus (27.6 %), Klebsiella pneumoniae (19.4 %), and Pseudomonas aeruginosa (16.2 %). Multidrug-resistant gram-negative bacteria exhibited 100 % susceptibility to colistin only. Klebsiella pneumoniae ESBL+ and Acinetobacter baumannii were most susceptible to carbapenems, while Pseudomonas aeruginosa strains to ceftazidime. Methicillin-resistant Staphylococcus aureus were 100 % susceptible to vancomycin, linezolid, and tigecycline. In conclusion, identifying the etiological factors causing infections of the lower respiratory tract and determining their drug-susceptibility is of key importance in empirical treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • American Thoracic Society (1996) Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy and preventive strategies. A consensus statement. Am J Respir Crit Care Med 153(5):1711–1725

    Article  Google Scholar 

  • American Thoracic Society (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171(4):388–416

    Article  Google Scholar 

  • Canadian Critical Care Trials Group (2006) A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 355(25):2619–2630

    Article  Google Scholar 

  • Celis R, Torres A, Gatell JM, Almela M, Rodriguez-Roisin R, Agusti-Vidal A (1988) Nosocomial pneumonia. A multivariate analysis of risk and prognosis. Chest 93(2):318–324

    Article  CAS  PubMed  Google Scholar 

  • Clinical and Laboratory Standards Institute (2011) Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement M100-S18. CLSI, Wayne. Accessed 12 Aug 2011

    Google Scholar 

  • Duszyńska W (2010) Antimicrobial therapy in severe infections with multidrug-resistant Gram-negative bacteria’s. Anestezjol Intens Ter 42(3):160–166

    PubMed  Google Scholar 

  • European Committee on Antimicrobial Susceptibility Testing (2011) EUCAST criteria. Available from: http://www.eucast.org. Accessed 12 Aug 2011

  • Goulding J, Snelgrove R, Saldana J, Didierlaurent A, Cavanagh M, Gwyer E, Wales J, Wissinger EL, Hussell T (2007) Respiratory infections: do we ever recover? Proc Am Thorac Soc 4(8):618–625

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hryniewicz W, Ozorowski T (2011) Hospital list of antibiotics. National Medicines Institute, Warszawa, pp 19–22

    Google Scholar 

  • Hryniewicz W, Grzesiowski P, Kozielski J, Kuś J, Meszaros J, Ozorowski T, Pirożyński M, Płusa T, Radzikowski A (2008) Recommendations for diagnostics and treatment of respiratory tract infections. National Program of Antibiotic Protection, Warszawa, pp 5–7

    Google Scholar 

  • Intensive Care Antimicrobial Resistance Epidemiology (1996) Surveillance report, data summary from January 1996 through December 1997: a report from the National Nosocomial Infections Surveillance System. Am J Infect Control 27(3):279–287

    Google Scholar 

  • Kelesidis T, Karageorgopoulos DE, Kelesidis I, Falagas ME (2008) Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J Antimicrob Chemother 62(5):895–904

    Article  CAS  PubMed  Google Scholar 

  • Kowalczyk W, Rybicki Z, Tomaszewski D, Truszczyński A, Guzek A (2011) The comparison of different bronchial aspirate culturing methods in patients with ventilator-associated pneumonia (VAP). Anestezjol Intens Ter 43(2):74–79

    PubMed  Google Scholar 

  • Lim WS, Macfarlane JT (2001) A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur Respir J 18(2):362–368

    Article  CAS  PubMed  Google Scholar 

  • Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, Rybak M, Talan DA, Chambers HF (2011) Clinical practice guidelines by the Infectious Diseases Society of America for treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 52(3):18–55

    Article  Google Scholar 

  • National Reference Center for Antimicrobial Susceptibility (2013) National Medicines Institute. National Laboratory of Medicinal Products, Medical Devices and Biocidal Products Control, Warsaw. Available from: http://www.il.waw.pl/eng/ZE.html. Accessed 10 Aug 2013

  • Płusa T (2013) Severe respiratory tract infections and rational antibiotic therapy. Int Rev Allergol Clin Immunol 1:7–11

    Google Scholar 

  • Rello J, Ulldemolins M, Lisboa T, Koulenti D, Manez R, Martin-Loeches I, De Waele JJ, Putensen C, Guven M, Deja M, Diaz E (2011) Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia. Eur Respir J 37(6):1332–1339

    Article  CAS  PubMed  Google Scholar 

  • Rybicki Z (2012) Antibiotherapy in the treatment of hospital acquired infections. Makmed, Lublin, pp 222–224

    Google Scholar 

Download references

Acknowledgments

We thank Dr. Andrzej Truszczyński from the Clinic of Anesthesiology and Intensive Care of the Military Institute of Medicine in Warsaw for his support during collecting the data. This work was supported by the Polish Ministry of Science and High Education (Theme no. 222/213, Military Institute of Medicine in Warsaw, Poland).

Conflicts of Interest

The authors declare no conflict of interest in relation to this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Korzeniewski .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Guzek, A. et al. (2014). Etiological Factors Causing Lower Respiratory Tract Infections Isolated from Hospitalized Patients. In: Pokorski, M. (eds) Respiratory Infections. Advances in Experimental Medicine and Biology(), vol 835. Springer, Cham. https://doi.org/10.1007/5584_2014_23

Download citation

Publish with us

Policies and ethics